Strategic Capital Investment in U.S. Pharmaceutical Manufacturing
Empowering Growth Through Innovation, Resilience, and Regulatory Excellence
In a rapidly evolving regulatory and market landscape, pharmaceutical companies must adopt a strategic approach to capital investment to remain competitive and compliant. KPMG delivers tailored support across the investment lifecycle—helping life sciences organizations expand, modernize, and future-proof their operations.
Why Invest Now?
From reshoring active pharmaceutical ingredient (API) production to adopting advanced manufacturing technologies, pharmaceutical companies face critical decisions. KPMG helps you:
1
2
3
4
Dive into our thinking:
Expanding Capital Investments in US
A Detailed, Strategic Approach for Business Growth in Pharmaceuticals
Download PDFSpecialized Capabilities
1
2
3
4
5
6
Let’s start a conversation about getting there
KPMG helps pharmaceutical companies develop infrastructure and capital project strategies, uncover funding opportunities, plan and manage programs, and deliver successful outcomes.
With the right combination of strategy, asset management, and data-enabled methodologies, organizations can build resilient, compliant, and future-ready operations.
Meet our team
